Pet Diabetes Care Devices Market Report 2026

Pet Diabetes Care Devices Market Overview

• Pet Diabetes Care Devices market size has reached to $2.74 billion in 2025 • Expected to grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Pet Ownership Drives The Pet Diabetes Care Device Market • Market Trend: Technologically Advanced Blood Glucose Monitoring System • North America was the largest region in 2025.

What Is Covered Under Pet Diabetes Care Devices Market?

Pet diabetes care devices are medical devices to treat pet diabetes through routine check-ups, blood and urine testing, and observation of the animal's weight, appetite, drinking, and urination. These devices control diabetic pets by keeping their blood sugar levels close to normal and preventing dangerously high or low levels. The main animal types in the market for pet diabetes care devices are dogs, cats, and horses. A dog is a four-legged creature that is frequently kept as a pet or employed for hunting. Pet diabetes care devices are used to monitor the health of diabetic dogs. The devices are glucose monitoring devices and insulin delivery devices, used by homecare, veterinary hospitals and others.

What Is The Pet Diabetes Care Devices Market Growth Forecast?

The pet diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancement in wearable glucose monitoring technology, integration of ai in pet healthcare, rising adoption of telemedicine for pets, expansion of smart pet care devices, growth of subscription-based veterinary services. Major trends in the forecast period include remote pet health monitoring, wearable diabetes tracking devices, personalized insulin delivery solutions, mobile app-integrated diabetes management, preventive health analytics for pets.

What Is The Driver Of The Pet Diabetes Care Devices Market?

The increasing pet ownership is expected to propel the growth of the pet diabetes care device market in the coming years. Pet ownership entails responsibilities such as providing food, water, housing, physical exercise, and healthcare for a domesticated animal such as a dog, cat, fish, bird, or other similar small animal. Pet diabetes care devices contribute significantly to the well-being of diabetic pets by enabling accurate monitoring, precise treatment, and effective communication between pet owners and veterinary professionals. For instance, in October 2023, according to the World Animal Foundation, a US-based website that supports animal rights, ethical pet ownership, and compassionate awareness, dog ownership was more common, with 65.1 million dogs compared with 46.5 million cats. Eleven million homes have saltwater fish tanks, compared to the 2.2 million horses owned by horse owners. Therefore, increasing pet ownership is driving the pet diabetes care device industry.

Key Players In The Global Pet Diabetes Care Devices Market

Major companies operating in the pet diabetes care devices market are Allison Medical Inc., Zoetis Inc., Becton Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Henry Schein Animal Health, Apotex Inc., Merck Co. Inc., Trividia Health Inc., UltiMed Inc., ACON Laboratories Inc., i-SENS Inc., TaiDoc Technology Corporation, Abbott Laboratories, Novo Nordisk AS, Covetrus AG, Eli Lilly and Company, Bayer AG, Terumo Corporation, AccuBioTech Co. Ltd., ALR Technologies Inc.

Global Pet Diabetes Care Devices Market Trends and Insights

Major companies operating in the pet diabetes care device market are developing innovative technologies to strengthen their position in the market. Innovative technologies refer to advanced glucose monitoring systems, connected insulin delivery devices, and digital health platforms that improve accuracy, ease of use, and long-term diabetes management in pets. For instance, in February 2023, Zoetis Inc., a US-based veterinary pharmaceutical company, launched the AlphaTrak 3 blood glucose monitoring system intended for cats and dogs in the United States. AlphaTrak 3 encompasses a new mobile app that allows owners of animals and veterinary medical professionals to gather, save, and share data. The AlphaTrak 3 blood glucose monitoring system enables effortless data exchange and communication via the smartphone app, making it quicker to share a pet's glucose levels and other essential details with the veterinary practice in real time and providing veterinarians and pet owners with increased confidence in diabetic pet care. The AlphaTrak 3 blood glucose monitoring device gives accurate information in as little as five seconds, which is quicker than the existing AlphaTrak 2 blood glucose monitoring system. AlphaTrak 3 uses only 0.3 microliters of blood and delivers a blood sugar dynamic that varies from 20 to 750 milligrams per deciliter. The new AlphaTrak 3 mobile app captures more data from pet owners than prior systems, including their pet's feeding, drinking, activity, and insulin administration timing.

What Are Latest Mergers And Acquisitions In The Pet Diabetes Care Devices Market?

In September 2025, Merck Animal Health, a US based provider of veterinary pharmaceuticals, vaccines, and animal health management solutions, partnered with Zoetis and Purina Pro Plan Veterinary Diets to enhance the management of diabetes in pets by pooling resources to provide education, tools, and diabetes management kits for veterinary clinics and pet owners. With this partnership, the companies aimed to strengthen their combined market reach in pet diabetes care, support early diagnosis and ongoing glucose monitoring practices, and improve outcomes for diabetic dogs and cats through coordinated educational and product support efforts. Zoetis Inc. is a US-based provider of veterinary diagnostics and therapeutic products, including blood glucose monitoring systems for pets, and Purina Pro Plan Veterinary Diets.

What Defines the Pet Diabetes Care Devices Market?

The pet diabetes care device market consists of sales of insulin delivery devices, insulin delivery pen and insulin syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pet Diabetes Care Devices Market Report 2026?

The pet diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pet diabetes care devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.